Agnès Dumas1,2, Rodrigue Allodji3,4, Brice Fresneau3,4,5, Dominique Valteau-Couanet5, Chiraz El-Fayech5, Hélène Pacquement6, Anne Laprie7, Tan Dat Nguyen8, Pierre-Yves Bondiau9, Ibrahima Diallo3,4, Catherine Guibout3,4, Carole Rubino3,4, Nadia Haddy3,4, Odile Oberlin5, Gilles Vassal4, Florent de Vathaire3,4. 1. Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France. agnes.dumas@gustaveroussy.fr. 2. Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France. agnes.dumas@gustaveroussy.fr. 3. Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France. 4. Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France. 5. Department of Paediatric and Adolescent Oncology, Gustave Roussy, 94805, Villejuif, France. 6. Department of Paediatric Oncology, Institut Curie, 75005, Paris, France. 7. Department of Radiation Oncology, Centre Claudius Regaud, 31059, Toulouse, France. 8. Radiotherapy Department, Centre Jean Godinot, 51100, Reims, France. 9. Department of Radiation Oncology, Centre Antoine Lacassagne, 06100, Nice, France.
Abstract
PURPOSE: Access to insurance for a loan or a mortgage is an important issue for childhood cancer survivors. The aim of this study was to describe difficulties experienced by adult survivors. METHODS: A total of 1920 survivors treated before the age of 18 in five French cancer centers responded to a questionnaire in 2010. Survivors who had tried to obtain a loan were asked if they had experienced difficulties, which were defined as experiencing rejection, higher premiums, or exclusions. The questionnaire investigated health problems related to the circulatory, respiratory, digestive, urinary, endocrine, hormonal, and nervous systems. Second tumors, diabetes mellitus, cardiac disease, and stroke were ascertained from a physician's report or medical records. Multivariable analyses were conducted to identify the characteristics of survivors reporting difficulties. RESULTS: Difficulties were experienced by 10.4% of those who had tried to obtain a small loan (n = 787) and by 30.1% of those who had tried to obtain a home loan (n = 909). Disclosure of childhood cancer to the insurer and amputation surgery were negatively associated with insurance accessibility, even when controlling for age, gender, education, health-related unemployment, familial situation, and severe or life-threatening conditions such as cardiovascular diseases, second cancers, or diabetes. CONCLUSION: This study showed that the financial burden of cancer can extend decades after diagnosis. IMPLICATIONS FOR CANCER SURVIVORS: Thanks to a 2016 law, French cancer survivors no longer have to disclose their cancer to insurers after a fixed number of years. This law will probably lessen the socioeconomic burden of cancer.
PURPOSE: Access to insurance for a loan or a mortgage is an important issue for childhood cancer survivors. The aim of this study was to describe difficulties experienced by adult survivors. METHODS: A total of 1920 survivors treated before the age of 18 in five French cancer centers responded to a questionnaire in 2010. Survivors who had tried to obtain a loan were asked if they had experienced difficulties, which were defined as experiencing rejection, higher premiums, or exclusions. The questionnaire investigated health problems related to the circulatory, respiratory, digestive, urinary, endocrine, hormonal, and nervous systems. Second tumors, diabetes mellitus, cardiac disease, and stroke were ascertained from a physician's report or medical records. Multivariable analyses were conducted to identify the characteristics of survivors reporting difficulties. RESULTS: Difficulties were experienced by 10.4% of those who had tried to obtain a small loan (n = 787) and by 30.1% of those who had tried to obtain a home loan (n = 909). Disclosure of childhood cancer to the insurer and amputation surgery were negatively associated with insurance accessibility, even when controlling for age, gender, education, health-related unemployment, familial situation, and severe or life-threatening conditions such as cardiovascular diseases, second cancers, or diabetes. CONCLUSION: This study showed that the financial burden of cancer can extend decades after diagnosis. IMPLICATIONS FOR CANCER SURVIVORS: Thanks to a 2016 law, French cancer survivors no longer have to disclose their cancer to insurers after a fixed number of years. This law will probably lessen the socioeconomic burden of cancer.
Entities:
Keywords:
Cohort studies; Discrimination; Economic burden of disease; Long-term adverse effects; Quality of life; Survivorship
Authors: Floortje Mols; Melissa S Y Thong; Pauline Vissers; Tamar Nijsten; Lonneke V van de Poll-Franse Journal: Eur J Cancer Date: 2011-12-21 Impact factor: 9.162
Authors: E M Noorda; R H J van Kreij; B C Vrouenraets; O E Nieweg; M Muller; B B R Kroon; N K Aaronson Journal: Eur J Surg Oncol Date: 2007-02-14 Impact factor: 4.424
Authors: F Joly; J F Héron; L Kalusinski; P Bottet; D Brune; N Allouache; J Macé-Lesec'h; J E Couëtte; J Pény; M Henry-Amar Journal: J Clin Oncol Date: 2002-01-01 Impact factor: 44.544
Authors: Anne C Kirchhoff; Wendy Leisenring; Kevin R Krull; Kirsten K Ness; Debra L Friedman; Gregory T Armstrong; Marilyn Stovall; Elyse R Park; Kevin C Oeffinger; Melissa M Hudson; Leslie L Robison; Thomas Wickizer Journal: Med Care Date: 2010-11 Impact factor: 2.983
Authors: Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison Journal: N Engl J Med Date: 2006-10-12 Impact factor: 176.079
Authors: S J Tamminga; U Bültmann; O Husson; J L P Kuijpens; M H W Frings-Dresen; A G E M de Boer Journal: Qual Life Res Date: 2015-09-22 Impact factor: 4.147
Authors: Laura Wengenroth; Grit Sommer; Matthias Schindler; Ben D Spycher; Nicolas X von der Weid; Eveline Stutz-Grunder; Gisela Michel; Claudia E Kuehni Journal: PLoS One Date: 2016-05-23 Impact factor: 3.240
Authors: Emily S Tonorezos; Dana Barnea; Richard J Cohn; Monica S Cypriano; Brice C Fresneau; Riccardo Haupt; Lars Hjorth; Yasushi Ishida; Jarmila Kruseova; Claudia E Kuehni; Purna A Kurkure; Thorsten Langer; Paul C Nathan; Jane E Skeen; Roderick Skinner; Nurdan Tacyildiz; Marry M van den Heuvel-Eibrink; Jeanette F Winther; Melissa M Hudson; Kevin C Oeffinger Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: Pernilla Lagergren; Anna Schandl; Neil K Aaronson; Hans-Olov Adami; Francesco de Lorenzo; Louis Denis; Sara Faithfull; Lifang Liu; Franḉoise Meunier; Cornelia Ulrich Journal: Mol Oncol Date: 2019-01-08 Impact factor: 6.603
Authors: Luigino Dal Maso; Chiara Panato; Stefano Guzzinati; Diego Serraino; Silvia Francisci; Laura Botta; Riccardo Capocaccia; Andrea Tavilla; Anna Gigli; Emanuele Crocetti; Massimo Rugge; Giovanna Tagliabue; Rosa Angela Filiberti; Giuliano Carrozzi; Maria Michiara; Stefano Ferretti; Rosaria Cesaraccio; Rosario Tumino; Fabio Falcini; Fabrizio Stracci; Antonietta Torrisi; Guido Mazzoleni; Mario Fusco; Stefano Rosso; Francesco Tisano; Anna Clara Fanetti; Giovanna Maria Sini; Carlotta Buzzoni; Roberta De Angelis Journal: Cancer Med Date: 2019-06-17 Impact factor: 4.452
Authors: Melissa S Y Thong; Daniela Doege; Linda Weißer; Lena Koch-Gallenkamp; Heike Bertram; Andrea Eberle; Bernd Holleczek; Alice Nennecke; Annika Waldmann; Sylke Ruth Zeissig; Ron Pritzkuleit; Michael Schlander; Hermann Brenner; Volker Arndt Journal: J Cancer Res Clin Oncol Date: 2021-10-13 Impact factor: 4.553